Molecular Oncology: Deciphering the Molecular Landscape of Cancer Treatment
A special issue of Genes (ISSN 2073-4425). This special issue belongs to the section "Human Genomics and Genetic Diseases".
Deadline for manuscript submissions: 25 October 2024 | Viewed by 94
Special Issue Editors
Interests: tumor suppressor; oncogene; signal transduction; actin cytoskeleton; mechanosignal transduction
Special Issues, Collections and Topics in MDPI journals
Interests: cancer cell biology; RB; E2F; ARF; p53
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Recent advances in molecular oncology have significantly extended prognosis through the development of targeted molecular therapies, diagnostic technologies, innovative gene therapy approaches, and the application of nucleic acid medicines. Despite these advances, the need for diverse therapeutic strategies remains critical for enhancing patient survival, given the complexities of achieving a complete cure with existing treatments.
This Special Issue aims to deepen our understanding of cancer by exploring the multifaceted interactions at the molecular level. It will focus on the molecular mechanisms involved in the initiation, progression, and treatment of cancer, emphasizing the dynamics of gene expression and subcellular structural changes in cancer cells and their microenvironment. Contributions may include original research papers and review articles discussing how factors such as fibroblasts influence cancer cell behaviors—proliferation, invasion, metastasis, and treatment response. Additionally, studies on cancer cell responses to therapeutic interventions, including gene therapy and nucleic acid medicines, and drug development are highly encouraged.
Dr. Keiko Kawauchi
Dr. Kiyoshi Ohtani
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Genes is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cancer
- gene mutation
- oncogene
- tumor suppressor
- metabolism
- organelle
- cytoskeleton
- microenvironment
- epigenetic regulation
- gene expression
- signal transduction
- mechanosignal transduction
- gene therapy
- nucleic acid medicine
